Use of the oxygen gradient ektacytometry in the dose titration of hydroxyurea therapy in children with sickle cell disease

被引：1
|
作者：
Houwing, Maite E. [1 ]
Bos, Jennifer [2 ]
van Wijk, Richard [2 ]
van Beers, Eduard J. [3 ]
Cnossen, Marjon H. [1 ]
Rab, Minke A. E. [2 ,4 ,5 ]
机构：
[1] Univ Med Ctr Rotterdam, Erasmus MC Sophia Childrens Hosp, Dept Pediat Hematol & Oncol, Rotterdam, Netherlands
[2] Univ Utrecht, Univ Med Ctr Utrecht, Cent Diagnost Lab Res, Utrecht, Netherlands
[3] Univ Med Ctr Utrecht, Utrecht Univ, Creveldkliniek, Utrecht, Netherlands
[4] Univ Med Ctr Rotterdam, Erasmus Med Ctr, Dept Hematol, Rotterdam, Netherlands
[5] Univ Utrecht, Cent Diagnost Lab Res, Univ Med Ctr Utrecht, Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands
来源：
INTERNATIONAL JOURNAL OF LABORATORY HEMATOLOGY | 2024年 / 46卷 / 02期
关键词：
BARRIERS;
D O I：
10.1111/ijlh.14208
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：390 / 394
页数：5
相关论文
共 50 条
  • [31] Hydroxyurea Therapy and Sleep-Disordered Breathing in Children With Sickle Cell Disease
    Abramson, Zachary
    Olanrewaju, Ayobami
    Kang, Guolian
    Olufadi, Yunusa
    Chen, Pei-Lin
    Rai, Parul
    Heitzer, Andrew M.
    Takemoto, Clifford M.
    Bashir, Ahsan
    Akil, Nour
    Hankins, Jane S.
    PEDIATRIC BLOOD & CANCER, 2025, 72 (04)
  • [32] Effect of hydroxyurea therapy on resting energy expenditure in children with sickle cell disease
    Fung, EB
    Barden, EM
    Kawchak, DA
    Zemel, BS
    Ohene-Frempong, K
    Stallings, VA
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2001, 23 (09) : 604 - 608
  • [33] Hydroxyurea in children with sickle cell disease: Impact on splenic function and compliance with therapy
    Olivieri, NF
    Vichinsky, EP
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 1998, 20 (01) : 26 - 31
  • [34] Effect of Hydroxyurea Therapy on Growth Parameters in Older Children with Sickle Cell Disease
    Alomairi, Anwar
    Almullabd, Sharef
    Khater, Doaa
    Al-Yaarubi, Saif
    Nazir, Hanan
    Wali, Yasser
    HORMONE RESEARCH IN PAEDIATRICS, 2016, 86 : 184 - 184
  • [35] HYDROXYUREA THERAPY INCREASES EXPRESSION OF BCAM/LU IN CHILDREN WITH SICKLE CELL DISEASE
    Johnson, Clarissa
    Telen, Marilyn
    PEDIATRIC BLOOD & CANCER, 2009, 52 (06) : 726 - 726
  • [36] Impact of hydroxyurea therapy on linear growth in children with sickle cell disease.
    Taylor, CM
    Symes, KN
    Muraca, MF
    Weerasinghe, DR
    Sharma, S
    Nili, N
    Olivieri, NF
    BLOOD, 1999, 94 (10) : 416A - 416A
  • [37] Value of hydroxyurea therapy in children severely affected with sickle cell disease.
    Oury, AP
    Hoyoux, C
    Dresse, MF
    Chantraine, JM
    ARCHIVES DE PEDIATRIE, 1997, 4 (09): : 839 - 844
  • [38] Use of hydroxyurea in children ages 2 to 5 years with sickle cell disease
    Hoppe, C
    Vichinsky, E
    Quirolo, K
    Van Warmerdam, J
    Allen, K
    Styles, L
    JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY, 2000, 22 (04) : 330 - 334
  • [39] Nutritional Status and Hydroxyurea Use Among Children with Sickle Cell Disease in Malawi
    Ellis, Graham
    Chipoka, Godwin
    Mafunga, Pilirani
    Heimlich, Jonathan Brett
    Mvalo, Tisungane
    Kamthunzi, Portia
    Kambalami, Isobel
    Westmoreland, Kate
    van der Gronde, Toon
    Wasswa, Peter
    Key, Nigel S.
    Ataga, Kenneth I.
    Nouraie, Mehdi
    Gopal, Satish
    BLOOD, 2016, 128 (22)
  • [40] Hydroxyurea Use for Sickle Cell Disease Among Medicaid-Enrolled Children
    Brousseau, David C.
    Richardson, Troy
    Hall, Matt
    Ellison, Angela M.
    Shah, Samir S.
    Raphael, Jean L.
    Bundy, David G.
    Arnold, Staci
    PEDIATRICS, 2019, 144 (01)
12345